Biotechnology company focused on using fermentation to produce cannabinoids for safe, legal, and effective consumer products and pharmaceuticals scales to 15,000-liter production runs of CBG BERKELEY, Calif., Sept. 3...
Cannabinoids
Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering
Long Beach, CA, Aug. 04, 2020 (GLOBE NEWSWIRE) — Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald”), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical...
